EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

EVALUATION OF PATIENT COUNSELLING THROUGH NEBULIZERS WITH COMORBIDITIES IN TERTIARY CARE HOSPITAL

Kanaganti Swathi, Saga Sunka, Punardeep Roy Karmakar, Sheereen Jahan Begum* and Anikul Islam

ABSTRACT

Aim: To evaluate the patient counselling through Nebulizers with comorbidities. Patients and Methods: All patients with disease complications who used nebulizers had to give written consent to a comprehensive medical history, age, gender, and drugs utilized in nebulizers. Results: In our patients who use nebulizers, we found that DUOLIN is the most commonly prescribed drug, followed by Budecort and Foracort. According to the disease, 42 percent of people have a BA, 77 percent have COPD, 52 percent have LRTI, and 6 percent have LRTI (OTHERS). The information gathered was very good and straightforward. The patient information leaflet was created to help patients understand how to use their nebulizers properly. The research indicates the therapeutic level of nebulizer medicines. determines that patients require medical education to achieve therapeutic levels. Conclusion: According to the findings, the use of nebulizers is widespread among those aged 50 to 80. DUOLIN was most commonly used in 42 percent of cases (BA), 77 percent of cases (COPD), 52 percent of cases (LRTI), and 46% of cases (OTHERS), according to the study. The p-value for all of the data was 0.0001, indicating that the data is significant at 0.05. According to this study, patients who use nebulizers have a low therapeutic level, which is due to a lack of medical expertise about nebulizer use. The patient information leaflet was created to advise patients on the proper use of nebulizers and the medications used in them, as well as their negative effects. This study was undertaken to determine nebulizer usage among 146 patients who most commonly utilized nebulizer drugs, as well as to raise awareness among patients about proper nebulizer usage and educate the public.

Keywords: Patient Counselling, Nebulizer, Respiratory tract Infections.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MAY ISSUE PUBLISHED

    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia